Google's Big Plan To Fund Change

Google has launched Project 10^100 (pronounced "Project 10 to the 100th"), a call for ideas that it has hopes for. The Mountain View, Calif. company has compiled a list of "16 big ideas," each inspired by numerous individual submissions from a call for action last fall.

Project 10^100 aims to find the best ideas that could change the world most, in hopes of helping as many people as possible. In that call for change, thousands of people from more than 170 countries submitted more than 150,000 ideas, from general investment suggestions to specific implementation proposals.

Google will fund up to five ideas, investing a total of $10 million. "Each project won't necessarily get $2 million, as one winning idea might warrant $3 million and another $1 million," according to a Google spokesperson.

Project 10^100 is a one-time project. Like most things at Google, no one person heads it; instead, the team works together. It was announced last year as part of Google's 10th birthday celebration. It draws on expertise from employees in various departments, so there is no one team of people working on just Project 10^100 and nothing else. It took 3,000 Googlers in offices worldwide to judge all submitted ideas.

advertisement

advertisement

Now Google wants people to vote on the ideas they should make happen. The rules state only one vote per person, but that vote can change up until the end of the voting period on Oct. 8. At that point, only your most recent vote counts. The vote will help Google's advisory board choose up to five projects to fund.

When choosing the "16 big ideas," Google did not focus on ideas that it would implement alone, but rather looked for those that require another organization's expertise or resources. These organizations will receive funding grants. Once up to five ideas are selected to receive funding, Google will reach out to relevant organizations to participate in a request for proposal process, according to the company's Web page.

Although the project may seem a bit daunting, it's not unusual for a company whose culture supports education, healthy lifestyles and playfulness. In the case of the New York City office, it's done through lending a helping hand when needed, self-powered scooters to speed Googlers from one end of the block-long Manhattan office complex to the other, and Lego building blocks piled high in bins against one wall of an open-area break room. It's all intended to motivate the mind.

3 comments about "Google's Big Plan To Fund Change".
Check to receive email when comments are posted.
  1. Mark Roth, September 25, 2009 at 6:02 p.m.

    Is there no link that can be addded to this story? Where do we go? Of course I will just Google it, but a nice link in the body would be nice.

  2. Laurie Sullivan from lauriesullivan, September 26, 2009 at 7:35 p.m.

    http://www.project10tothe100.com/

  3. Sergey Serdyuk from Gevys , October 12, 2009 at 4:41 p.m.

    My projects Google rejected .
    May be this projects will be interesting for my friends

    Sergey Serdyuk

    1. "method for potentiating drugs"
    Electrical vagus stimulation is considered as the most effective method of treatment of such diseases as epilepsy, depression, chronic pain, drug addiction, obesity, resisted to action of drugs. However the mentioned method demands expensive operation and is not safe (it can cause cardiac arrest, bronchospasm, abdominal pains and other complications.). I suggest safe method of the chemical stimulation of the receptors of vagal afferents by agonists of peripheral receptors: cholecystokinin (CCK), glutamate, ??P, epinephrine, phenylephrine, carbacholine and adenosine, weakly penetrating into CNS, which in small, not causing side-effects doses after systemic or oral administration selectively stimulate chemoceptors of vagal afferents. Chemical stimulation of vagal afferents by agonists of peripheral receptors eliminates pain, depression, anxiety, convulsions, hypoxia, inflammation, neurodegeneration, psychosis,extrapyramidal disorder , stress disorder, that the most important thing, in tens and hundreds times potentiates action of analgesics, antidepressants, antiepileptics, neuroleptics, antiparkinsonian drugs, neuroprotective drugs, antihypoxic agent, stress protective agents without increasing of side- effects of drugs (US patent 6.833.377, US patent application 20050192220). In contrast to expensive and unsafe method of the electrical vagus stimulation the offered method of chemical vagus stimulation is safe, cheap and accessible to patients as allows to use agonists of peripheral receptors in the standard dosage form (solutions, tablets, syrups, granules) or can be added to dosage form of known drugs. The method does not have any disadvantages, except one - he is not necessary to known pharmaceutical companies as decreases of doses of drugs and, in addition, substitution of these drugs to cheap stimulators of vagal afferents (which any patient can independently use) may cause to drop in profit of pharmaceutical firms. The idea can be realised quickly enough, for two years term because the used substances are allowed to clinical application. As a whole, the idea is devoted to the problem of creating of the simple and accessible method of chemical stimulation of vagus for the purpose of mass treatment of many diseases, and also potentiation of effects of analgesics, antidepressants, neuroleptics, antiepileptics, antiparkinsonian drugs, neuroprotective drugs, anti-inflammatory drugs, antihypoxics agent, stress protective agents without side-effects and complications. Realisation of the idea will allow to reduce considerably doses and to eliminate side-effects of known drugs, and in the long term - to substitute these drugs with much cheaper chemical stimulators of vagal afferents which any patient can independently use without limitation. Means are necessary for carrying out of the preclinical researches in animal models of pain, depression, epilepsy, parkinsonism, hypoxia, anxiety, psychosis, neurodegeneration, inflammation and also for carrying out of toxicological researches in animals. At the second stage it is supposed to estimate safety of the method on volunteers and to spend 1 stage of clinical trials. Successful completion of preclinical and clinical experiments will allow to suggest simple and accessible method of chemical stimulation of vagus for treatment of many illnesses, and also method of potentiation of effect of analgetics, antidepressants, neuroleptics, antiepileptics, antiparkinsonian drugs, anti-inflammatory drugs, neuroprotective drugs, antihypoxic agent, stress protective agents without side-effects and complications. The references: 1) Patent US 6,833,377. S. Serdyuk, Composition and method for potentiating drugs. 2) Patent Application Publication Pub. No.0192220. S. Serdyuk, Composition and method for potentiating drugs. 3) Serdyuk S.E., Gmiro V.E., Epinephrine potentiates the analgesic and antidepressant effects of polyvinylpyrrolidone and cholecystokinin due to stimulation of afferents in the gastric mucosa. Bull. Exp. Biol. Med. 2007, 143(3): 350-352. 4) Gmiro V.E., Serdyuk S.E. Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats. Bull. Exp. Biol. Med. 2007, 143(5): 617-619. 5) Gmiro V.E., Serdyuk S.E. Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats. Bull. Exp. Biol. Med. 2007, 143(5): 617-619.

    2. "The method stimulation of vagal afferents for treatment of pain and potentiation of analgesic action of opiates without development of tolerance and drug addiction . I suggest original and safe method of selective chemical stimulation of subdiaphragmatic vagal afferents for treatment of pain and potentiation of analgesic action of opiates without development of tolerance and drug addiction. The method consists in systemic or oral administration of agonists of peripheral receptors: cholecystokinin (CCK), glutamate, ??P, adrenaline and adenosine, weakly penetrating into CNS, in small, not causing side-effect doses. It is known, that the maximum analgesic action of opiates occurs only in the high doses causing numerous side-effects and complications, including development of tolerance and addiction to opiates. I suggest the original and safe method of selective chemical stimulation of the subdiaphragmatic vagal afferents, designed for treatment of pain and potentiation of effect of low doses of opiates without development of tolerance and addiction to opiates. Stimulation of vagal afferents is achieved by systemic or oral administration of agonists of peripheral receptors: cholecystokinin (CCK), glutamate, ??P, adrenaline and adenosine, weakly penetrating into CNS in small, not causing side-effects doses (US patent application 20050192220). The above-mentioned method can be used also for elimination of side-effects and complications of the maximal possible doses of opiates, including development of tolerance and addiction to opiates. The idea can be realised quickly enough, for two years term because the used substances are allowed to clinical application. The method does not any disadvantages, except one - it is not necessary to known pharmaceutical companies as decrease of doses of drugs and especially changing of these drugs by stimulators of vagal afferents (which any patient can independently use) will lead to elimination of tolerance and addiction to opiates and consequently, to catastrophic falling of demand for narcotic analgetics and narcotics.As a whole, the idea is devoted to the problem of creating of the simple and accessible method of chemical stimulation of vagus for mass treatment of acute and chronic pain, without development of tolerance and drug addiction. The offered method can be used not only for potentiation of analgesic action of morphine and other opiates in small doses, but also for elimination of their side-effects and complications in case of using of narcotic analgesics in maximal possible doses.Realisation of the idea will allow to reduce considerably doses and to eliminate side-effects of known narcotic analgesics , and in the long term to change opiates with much cheaper chemical stimulators of vagal afferents which any patient can independently use without limitation. Means are necessary for carrying out of the preclinical researches in animal models of acute and chronic pain ,hyperalgesia ,tolerarance and addiction to opiates , and also for carrying out of toxicological researches in animals. At the second stage it is supposed to estimate safety of the method on volunteers and to spend 1 stage of clinical trialsSuccessful completion of preclinical and clinical experiments will allow to suggest simple and accessible method of chemical stimulation of vagus for treatment of acute and chronic pain ,hyperalgesia , tolerance and addiction to opiates , and also method of potentiation of analgesic effect of opiates in small doses without side-effects and complications. The above-mentioned method can be used also for elimination of side-effects and complications of the maximal possible doses of opiates, including development of tolerance and addiction to opiates The references: 1) Patent US 6,833,377. S. Serdyuk, Composition and method for potentiating drugs. 2) Patent Application Publication Pub. No.0192220. S. Serdyuk, Composition and method for potentiating drugs. 3) Serdyuk S.E., Gmiro V.E., Epinephrine potentiates the analgesic and antidepressant effects of polyvinylpyrrolidone and cholecystokinin due to stimulation of afferents in the gastric mucosa. Bull. Exp. Biol. Med. 2007, 143(3): 350-352. 4) Gmiro V.E., Serdyuk S.E. Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats. Bull. Exp. Biol. Med. 2007, 143(5): 617-619. 5) Gmiro V.E., Serdyuk S.E. Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats. Bull. Exp. Biol. Med. 2007, 143(5): 617-619. _____________________________________________________________

Next story loading loading..